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1. INTRODUCTION 
1.1.MEDICINAL PLANTS 
         India has a rich Culture of  Medicinal herbs and spices, Which includes about 
more than 2000 species and has a vast geographical area With high potential abilities 
for Ayurvedic, Unani, Siddha traditional medicines but only few have been studied 
chemically and Pharmacologically for their potential medicinal value 
(1)
. 
          Herbal molecules are safe and could overcome the resistance produced by the 
pathogens as they exist in a combined form or in a pooled form of more than one 
molecule in the protoplasm of the plant cell. 
1.2.  ROLE OF HERBAL MEDICINES IN HEALTH CARE SYSTEM 
             Medicinal herbs play an important role in primary health care system among 
rural population since synthetic anti-cancer remedies  are  beyond the reach of 
common man because of the cost factor. The herbal medicines have a vital role in the 
prevention and treatment of cancer. Which execute their therapeutic effect by 
inhibiting cancer activating ezymes and hormones , stimulating DNA repair 
mechanism. 
(2)
. 
             People living in rural areas from their personal experience know that these 
traditional remedies are valuable source of  natura l products to maintain human 
health, but they may not understand the science  behind these  medicines, but know 
that some medicinal plants are highly effective only when used at therapeutic doses. 
               A survey of current pharmaceutical use revealed that of the total prescription 
drugs dispensed 25% are plant derived. Plant compounds are highly varied in 
structure; many are aromatic substance which are phenols or their oxygen –substituted 
derivatives. However, there is an increased attention on extracts and biologically 
active compounds isolated from plant species used in herbal medicine, due to its side 
effects and the resistance that pathogenic micro-organism build against the antibiotics.
  
               Plant constituents may be isolated and used directly as therapeutic agents or 
as starting materials for drug synthesis or they may serve as models for 
pharmacologically active compounds in drug synthesis. The general research methods 
includes proper selection of medicinal plant preparation of crude extract ,biological 
screening, detailed chemo pharmacological investigations, toxicological and clinical 
CHAPTER1                                                                                        INTRODUCTION 
 
J.K.K.Nattraja College of Pharmacy,Komarpalayam Page 2 
 
studies, standardization and  use of active moiety as the lead molecule for drug design
 
(3)
 
1.3. ANCIENT INDIAN SYSTEM OF MEDICINE  
           Ayurveda is an ancient Indian system of medicine that makes use of herbs 
existing in the nature and formulates herbal remedies using the inherent power present 
in these herbs.
 (4)
 
            Ayurveda uses the inherent power of natural herbs to bring about wonderful 
results on human body. The herbs are natural and 100% safe. Cancer in ayurveda 
helps stop the abnormal growth of cells. In later stages of the cancer help relieve pain 
and anxiety. It helps relive patient from the unearthly pain and suffering. 
            Herbal medicines have a vital role in the prevention and treatment of cancer. A 
great deal of Pharmaceutical research done in technologically advanced countries like 
USA, Germany, France, Japan and China has considerably improved quality of the 
herbal medicines used in the treatment of cancer.
(5) 
With advanced knowledge of molecular science and refinement in isolation 
and structure elucidation techniques, we are in a much better position to identify 
various anticancer herbs is executed by inhibiting cancer activing enzymes, 
stimulating DNA repair mechanism, promoting production of protective enzymes, 
inducing antioxidant action by enhancing activity of the immune cells, some protect 
the body from cancer by enhancing detoxification  functions of the body. Certain 
biological response modifiers derived from herbs are to known to inhibit growth of 
cancer by modulating the activity of specific hormones and enzymes. Some herbs 
reduce toxic side effects of chemotherapy and radiotherapy . 
Scientist all over the world are concentrating on the herbal medicines to boost 
immune cells of the body against cancer. By understanding the complex synergistic 
interaction of various constituents of anti cancer herbs, the herbal formulations can be 
designed to attack the cancerous cells without harming normal cells of the body.
(6) 
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1.4.  TUMOR 
It is a group of diseases involving abnormal cell growth with the potential to 
invade or spread to other parts of the body 
 
 Not all tumors are cancerous; benign 
tumors do not spread to other parts of the body 
 
 Possible signs and symptoms include 
a lump, abnormal bleeding, prolonged cough, unexplained weight loss and a change 
in bowel movements.   While these symptoms may indicate cancer, they may have 
other causes   Over 100 types of cancers affect humans. 
1.5 COLLECTION OF RELATED DISEASE: 
Cancer is the name given to a collection of related diseases. In all types of cancer, 
some of the body’s cells begin to divide without stopping and spread into surrounding 
tissues. Cancer can start almost anywhere in the human body, which is made up of 
trillions of cells. Normally, human cells grow and divide to form new cells as the 
body needs them. When cells grow old or become damaged, they die, and new cells 
take their place.
 
When cancer develops, however, this orderly process breaks down. As cells 
become more and more abnormal, old or damaged cells survive when they should die, 
and new cells form when they are not needed. These extra cells can divide without 
stopping and may form growths called tumors.
 (7) 
Many cancers form solid tumors, which are masses of tissue. Cancers of the 
blood, such as leukemias, generally do not form solid tumors. Cancerous tumors are 
malignant, which means they can spread into, or invade, nearby tissues. In addition, as 
these tumors grow, some cancer cells can break off and travel to distant places in the 
body through the blood or the lymph system and form new tumors far from the 
original tumor. 
 
Unlike malignant , benign tumors do not spread into, or invade, nearby tissues. 
This can sometimes be quite large, however. When removed, they usually don’t grow 
back, whereas malignant tumors sometimes do. Unlike most benign tumors elsewhere 
in the body, benign brain tumors can be life threatening. 
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1.5.DIFFERENCE BETWEEN CANCER CELLS AND NORMAL CELLS : 
Cancer cells differ from normal cells in many ways that allow them to grow out of 
control and become invasive. One important difference is that cancer cells are less 
specialized than normal cells. That is, whereas normal cells mature into very distinct 
cell types with specific functions, cancer cells do not. This is one reason that, unlike 
normal cells, cancer cells continue to divide without stopping.
 (8)
 
In addition, cancer cells are able to ignore signals that normally tell cells to stop 
dividing or that begin a process known as programmed cell death, or apoptosis, which 
the body uses to get rid of un needed cells. 
Cancer cells may be able to influence the normal cells, molecules, and blood 
vessels that surround and feed a tumor an area known as the micro environment. For 
instance, cancer cells can induce nearby normal cells to form blood vessels that 
supply tumors with oxygen and nutrients, which they need to grow. These blood 
vessels also remove waste products from tumors. 
Cancer cells are also often able to evade the immune system, a network of organs, 
tissues, and specialized cells that protects the body from infections and other 
conditions. Although the immune system normally removes damaged or abnormal 
cells from the body, some cancer cells are able to “hide” from the immune system.(9) 
Tumors can also use the immune system to stay alive and grow. For example, with 
the help of certain immune system cells that normally prevent a run away  immune 
response cancer cells can actually keep the immune system from killing cancer cells. 
1.6. HOW CANCER ARISES  
Cancer is a genetic disease that , it is caused by changes to genes that control the 
way our cells function, especially how they grow and divide. 
Genetic changes that cause cancer can be inherited from our parents. They can 
also arise during a person’s lifetime as a result of errors that occur as cells divide or 
CHAPTER1                                                                                        INTRODUCTION 
 
J.K.K.Nattraja College of Pharmacy,Komarpalayam Page 5 
 
because of damage to DNA caused by certain environmental exposures. Cancer-
causing environmental exposures include substances, such as the chemicals in tobacco 
smoke, and radiation, such as ultraviolet rays from the sun. Each person’s cancer has 
a unique combination of genetic changes. As the cancer continues to grow, additional 
changes will occur. Even within the same tumor, different cells may have different 
genetic changes. 
In general, cancer cells have more genetic changes, such as mutations in DNA, 
than normal cells. Some of these changes may have nothing to do with the cancer; 
they may be the result of the cancer, rather than its cause. 
1.7. DRIVERS OF CANCER 
The genetic changes that contribute to cancer tend to affect three main types of 
genes Proto-oncogenesis tumour suressor genes, and DNA repair genes. These 
changes are sometimes called “drivers” of cancer. 
Proto-oncogenes are involved in normal cell growth and division. However, when 
these genes are altered in certain ways or are more active than normal, they may 
become cancer-causing genes (or oncogenes), allowing cells to grow and survive 
when they should not.
(10)
 Tumor suppressor genes are also involved in controlling cell 
growth and division. Cells with certain alterations in tumor suppressor genes may 
divide in an uncontrolled manner. 
DNA repair genes are involved in fixing damaged DNA. Cells with mutations in 
these genes tend to develop additional mutations in other genes. Together, these 
mutations may cause the cells to become cancerous. 
As scientists have learned more about the molecular changes that lead to cancer, 
they have found that certain mutations commonly occur in many types of cancer. 
Because of this,  
cancers are sometimes characterized by the types of genetic alterations that are 
believed to be driving them, not just by where they develop in the body and how the 
cancer cells look under the microscope.
(11) 
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1.7.WHEN CANCER SPREADS 
A cancer that has spread from the place where it first started to another place in 
the body is called metastatic cancer. The process by which cancer cells spread to other 
parts of the body is called metastasis.
(12)
 
Metastatic cancer has the same name and the same type of cancer cells as the 
original, or primary, cancer. For example, breast cancer that spreads to and forms a 
metastatic tumor in the lung is metastatic breast cancer, not lung cancer. 
Under a microscope, metastatic cancer cells generally look the same as cells of the 
original cancer. Moreover, metastatic cancer cells and cells of the original cancer 
usually have some molecular features in common, such as the presence of specific 
chromosome changes. 
Metastasis is the spread of cancer to other locations in the body. The dispersed 
tumors are called metastatic tumors, while the original is called the primary tumor. 
Almost all cancers can metastasize. Most cancer deaths are due to cancer that has 
metastasized
 
.. It is common in the late stages of cancer and it can occur via the blood 
or the lymphatic  system or both. The typical steps in metastasis are local invasion, 
intravasation into the blood or lymph, circulation through the body, extravasation into 
the new tissue, proliferation and angiogenesis. Different types of cancers tend to 
metastasize to particular organs, but overall the most common places for metastases to 
occur are the lungs, liver, brain and the bones.
 
 In Metastasis, Cancer cells break away from where they first formed (primary 
cancer), travel through the blood  lymph system, and form new tumors (metastic 
tumors) in other parts of the body. 
Treatment may help prolong the lives of some people with metastatic cancer. In 
general, though, the primary goal of treatments for metastatic cancer is to control the 
growth of the cancer or to relieve symptoms caused by it. It can cause severe damage 
to how the body functions, and most people who die of cancer die of metastatic 
disease.   
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Fig.no.1 
1.8.TISSUE CHANGES THAT ARE NOT A CANCER 
Not every change in the body’s tissues is cancer. Some tissue changes may 
develop into cancer if they are not treated, however. Here are some examples of tissue 
changes that are not cancer but, in some cases, are monitored: 
Hyperplasia occurs when cells within a tissue divide faster than normal and extra 
cells build up, or proliferate. However, the cells and the way the tissue is organized 
look normal under a microscope. Hyperplasia can be caused by several factors or 
conditions, including chronic irritation.
(13)
 
Dysplasia is a more serious condition than hyperplasia. In dysplasia, there is also 
a build up of extra cells. But the cells look abnormal and there are changes in how the 
tissue is organized. In general, the more abnormal the cells and tissue look, the greater 
the chance that cancer will form.
(14)
 
Some types of dysplasia may need to be monitored or treated. An example of 
dysplasia is an abnormal mole (called a dysplastic nevus) that forms on the skin. A 
dysplastic nerves can turn into melanoma, although most do not. 
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An even more serious condition is carcinoma in situ. Although it is sometimes 
called cancer, carcinoma in site is not cancer because the abnormal cells do not spread 
beyond the original tissue. That is, they do not invade nearby tissue the way that 
cancer cells do. But, because some carcinomas in situ may become cancer, they are 
usually treated.
 (14) 
 
 
Fig.No. 2. 
Normal cells may become cancer cells form in tissues of the body, the cells go 
through abnormal changes called hyperplasia and dysplasia. In hyperplasia, there is an 
increase in the number of cells in an organ or tissue that appear normal under a 
microscope. In dysplasia, the cells look abnormal under a microscope but are not 
cancer. Hyperplasia and dysplasia may or may not become cancer. 
1.9.TYPES OF CANCER 
 There are more than 100 types of cancer. Types of cancer are usually named for the 
organs or tissues where the cancers form. For example, lung cancer starts in cells of 
the lung, and brain cancer starts in cells of the brain. Cancers also may be described 
by the type of cell that formed them, such as an epithelial cell or a squamous cell.
 (14) 
Here are some categories of cancers that begin in specific types of cells. 
 CARCINOMA 
Carcinomas are the most common type of cancer. They are formed by 
epithelial cells, which are the cells that cover the inside and outside surfaces of the 
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body. There are many types of epithelial cells, which often have a column-like shape 
when viewed under a microscope.
 
 
Carcinomas that begin in different epithelial cell types have specific names: 
ADENOCARCINOMA  
It is a cancer that forms in epithelial cells that produce fluids or mucus. Tissues 
with this type of epithelial cell are sometimes called glandular tissues. Most cancers 
of the breast, colon, and prostate are adenocarcinomas. 
BASAL CELL CARCINOMA  
It is a cancer that begins in the lower or basal (base) layer of the epidermis, which 
is a person’s outer layer of skin. 
SQUAMOUS CELL CARCINOMA  
It is a cancer that forms in squamous cells, which are epithelial cells that lie just 
beneath the outer surface of the skin. Squamous cells also line many other organs, 
including the stomach, intestines, lungs, bladder, and kidneys. Squamous cells look 
flat, like fish scales, when viewed under a microscope. Squamous cell carcinomas are 
sometimes called epidermoid carcinomas
.(15). 
TRANSITIONAL CELL CARCINOMA 
It is a cancer that forms in a type of epithelial tissue called transitional epithelium, 
or urothelium. This tissue, which is made up of many layers of epithelial cells that can 
get bigger and smaller, is found in the linings of the bladder, ureters, and part of the 
kidneys (renal pelvis), and a few other organs. Some cancers of the bladder, ureters, 
and kidneys are transitional cell carcinomas. 
SARCOMA 
Sarcomas are cancers that form in bone and soft tissues, including muscle, fat, 
blood vessels, lymph vessels and fibrous tissue (such as tendons and ligaments). 
Osteosarcoma is the most common cancer of bone. 
LEUKIMIA 
Cancers that begin in the blood-forming tissue of the bone marrow are called 
leukemias. These cancers do not form solid tumors. Instead, large numbers of 
abnormal white blood cells (leukemia cells and leukemic blast cells) build up in the 
blood and bone marrow, crowding out normal blood cells. The low level of normal 
CHAPTER1                                                                                        INTRODUCTION 
 
J.K.K.Nattraja College of Pharmacy,Komarpalayam Page 10 
 
blood cells can make it harder for the body to get oxygen to its tissues, control 
bleeding, or fight infections
.(16)
   
LYMPHOMA 
Lymphoma is cancer that begins in lymphocytes (T cells or B cells). These are 
disease-fighting white blood cells that are part of the immune system. In lymphoma, 
abnormal lymphocytes build up in lymph nodes and lymph vessels, as well as in other 
organs of the body.
 (14)
 
OTHER TYPES OF TUMOURS 
 GERM CELL TUMOUR 
Germ cell tumors are a type of tumor that begins in the cells that give rise to 
sperm or eggs. These tumors can occur almost anywhere in the body and can be either 
benign or malignant
.(17) 
NEUROENDOCRINE TUMOURS 
Neuroendocrine tumors form from cells that release hormones into the blood 
in response to a signal from the nervous system. These tumors, which may make 
higher-than-normal amounts of hormones, can cause many different symptoms. 
Neuroendocrine tumors may be benign or malignant 
CARCINOID TUMOURS 
Carcinoid tumors are a type of neuroendocrine tumor. They are slow-growing 
tumors that are usually found in the gastrointestinal system (most often in the rectum 
and small intestine). Carcinoid tumors may spread to the liver or other sites in the 
body, and they may secrete substances such as serotonin or prostaglandins, causing 
carcinoid syndrome.
 (18) 
COMMON TYPES OF CANCER 
Cancer  is  a  common  condition  and  is  a  serious  health  problem,  both  in  
the UK    and across the world. It  is estimated  that 7.6 million people in  the world 
died of cancer  in 2007. In the UK, cancer is responsible for 126,000 deaths per year. 
One in four people die from cancer. 
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Fig. No: 3 
There are hundreds of different types of cancer. The most common cancers  are: 
 1.Breast  cancer,  
 2. Prostate  cancer,  
 3. Lung cancer, 
 4. Cancer of colon or rectum, 
 5. Blood cancer, 
 6. Bladder cancer, 
 7. Liver Cancer, 
 8. Ovarian cancer  
 
1.13. RISK FACTORS OF CANCER 
 It is usually not possible to know exactly why one person develops cancer and 
another doesn’t. But research has shown that certain risk factors may increase 
a person’s chances of developing cancer. 
 Cancer risk factors include exposure to chemicals or other substances, as well 
as certain behaviors. They also include things people cannot control, like age 
and family history.  
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 A family history of certain cancers can be a sign of a possible inherited cancer 
syndrome. Most cancer risk (and protective) factors are initially identified in 
epidemiology studies.   
 Although some of these risk factors can be avoided, others-such as growing 
older-cannot. Limiting your exposure to avoidable risk factors may lower your 
risk of developing certain cancers  
 Age 
 Alcohol 
 Cancer-Causing Substances 
 Chronic Inflammation 
 Diet 
 Hormones 
 Immunosuppression 
 Infectious Agents 
 Obesity 
 Radiation 
 Sunlight 
 Tobacco 
1.15. COLORECTAL CANCER (CRC) 
It also known as bowel cancer and colon cancer, is the development of cancer 
from the colon or rectum (parts of the large intestine). A cancer is the abnormal 
growth of cells that have the ability to invade or spread to other parts of the body. 
Signs and symptoms may include blood in the stool, a change in bowel movements, 
weight loss, and feeling tired all the time
(19)
 
          Most colorectal cancers are due to old age and lifestyle factors with only a 
small number of cases due to underlying genetic disorders. Some risk factors include 
diet, obesity, smoking, and lack of physical activity
,
  
Dietary factors that increase the risk include red and processed meat as well as 
alcohol, Another risk factor is inflammatory bowel disease which includes Crohn's 
disease and ulcerative colitis. Some of the inherited genetic disorders that can cause 
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colorectal cancer include familial adenomatous polyposis and hereditary non-
polyposis colon cancer, however, these represent less than 5% of cases It typically 
starts as a benign tumor, often in the form of a polyp, which over time becomes 
cancerous
(20).
 
COLON CANCER 
 
Fig. No: 4 
1.16. SIGNS AND SYMPTOMS 
The classic warning signs include: 
 worsening constipation, 
 blood in the stool, 
 decrease in stool caliber (thickness), 
 loss of appetite, 
 loss of weight, 
 Nausea or vomiting in someone over 50 years old. 
1.17. CAUSES 
     Greater than 75–95% of colorectal cancer occurs in people with little or no genetic 
risk.Risk factors include older age, male gender high intake of fat, alcohol, red meat, 
processed meats, obesity, smoking, and a lack of physical exercise.Approximately 
10% of cases are linked to insufficient activity The risk for alcohol appears to increase 
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at greater than one drink per day Drinking 5 glasses of water a day is linked to a 
decrease in the risk of colorectal cancer and adenomatous polyps
.(21)
  
1.18. INFLAMMATORY BOWEL DISEASE 
People with inflammatory bowel disease (ulcerative colitis and Crohn's 
disease) are at increased risk of colon cancer. The risk increases the longer a person 
has the disease, and the worse the severity of inflammation. In these high risk groups, 
both prevention with aspirin and regular colonoscopies are recommended. People 
with inflammatory bowel disease account for less than 2% of colon cancer cases 
yearly
. 
 In those with Crohn's disease 2% get colorectal cancer after 10 years, 8% after 
20 years, and 18% after 30 years
(22).
 In those with ulcerative colitis approximately 
16% develop either a cancer precursor or cancer of the colon over 30 years.
 
1.19. GENETICS 
Those with a family history in two or more first-degree relatives (such as a 
parent or sibling) have a two to three fold greater risk of disease and this group 
accounts for about 20% of all cases. A number of genetic syndromes are also 
associated with higher rates of colorectal cancer.  
1.21. LUNG CANCER 
It also known as lung carcinoma is a malignant lung tumour characterized by 
uncontrolled cell growth in tissues of the lung. If left untreated, this growth can spread 
beyond the lung by the process of metastasis into nearby tissue or other parts of the 
body
. 
Most cancers that start in the lung, known as primary lung cancers, are 
carcinomas. The two main types are small-cell lung carcinoma (SCLC) and non-
small-cell lung carcinoma (NSCLC)
 
The most common symptoms are coughing 
(including coughing up blood, weight loss, shortness of breath, and chest pains
 (23)
    
The vast majority (85%) of cases of lung cancer are due to long-term tobacco 
smoking, About 10–15% of cases occur in people who have never smoked, These 
cases are often caused by a combination of genetic factors  and exposure to radon gas, 
asbestos, second-hand smoke, or other forms of air pollution, Lung cancer may be 
CHAPTER1                                                                                        INTRODUCTION 
 
J.K.K.Nattraja College of Pharmacy,Komarpalayam Page 15 
 
seen on chest radiographs and computed tomography (CT) scan.  The diagnosis is 
confirmed by biopsy which is usually performed by bronchoscopy or CT-guidance. 
Avoidance of risk factors, including smoking and air pollution, is the primary 
method of prevention. Treatment and long-term outcomes depend on the type of 
cancer, the stage (degree of spread), and the person's overall health. Most cases are 
not curable Common treatments include surgery, chemotherapy, and 
radiotherapy.NSCLC is sometimes treated with surgery, whereas SCLC usually 
responds better to chemotherapy and radiotherapy.. 
Worldwide in 2012, lung cancer occurred in 1.8 million people and resulted in 
1.6 million deaths. This makes it the most common cause of cancer-related death in 
men and second most common in women after breast cancer. The most common age 
at diagnosis is 70 years. Overall, 17.4% of people in the United States diagnosed with 
lung cancer survive five years  after the diagnosis, while outcomes on average are 
worse in the developing world
(24) 
LUNG CANCER 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. No: 5 
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1.23. SIGNS AND SYMPTOMS 
      Signs and symptoms which may suggest lung cancer include: 
 Respiratory symptoms: coughing, coughing up blood, wheezing, or shortness 
of breath 
 Systemic symptoms: weight loss, weakness, fever, or clubbing of the 
fingernails 
 Symptoms due to the cancer mass pressing on adjacent structures: chest pain, 
bone pain, superior vena cava obstruction, or difficulty swallowing. 
1.24. RISK FACTOR 
 Cancer develops following genetic damage to DNA and epigenetic changes. 
These changes affect the normal functions of the cell.
 
 Smoking, particularly of cigarettes, is by far the main contributor to lung 
cancer. Cigarette smoke contains at least 73 known carcinogens, including 
benzo[a]pyrene, NNK.
 
 Passive smoking the inhalation of smoke from another's smoking is a cause 
of lung cancer in nonsmokers. A passive smoker can be defined as someone 
living or working with a smoker.
 
 Outdoor air pollutants, especially chemicals released from the burning of 
fossil fuels, increase the risk of lung cancer. Fine particulates (PM2.5) and 
sulfate aerosols, which may be released in traffic exhaust fumes. 
 
1.25. LIVER CANCER 
It also known as hepatic cancer and primary hepatic cancer, is cancer that 
starts in the liver, Cancer which has spread from elsewhere to the liver, known as liver 
metastasis is more common than that which starts in the liver. Symptoms of liver 
cancer may include a lump or pain in the right side below the rib cage, swelling of the 
abdomen yellowish skin, easy bruising, weight loss, and weakness
(25).
     The leading 
cause of liver cancer is cirrhosis due to either hepatitis B hepatitis C or alcohol
 
Other 
causes include aflatoxin non-alcoholic fatty liver disease, and liver flukes. 
CHAPTER1                                                                                        INTRODUCTION 
 
J.K.K.Nattraja College of Pharmacy,Komarpalayam Page 17 
 
The most common types are hepatocellular carcinoma (HCC), which makes 
up 80% of cases, and cholangiocarcinoma. Less common types include mucinous 
cystic neoplasm and intraductal papillary biliary neoplasm. The diagnosis may be 
supported by blood tests and medical imaging with confirmation by tissue biopsy
.
 
Preventive efforts include immunization against hepatitisB and treating those 
infected with hepatitis B or C. Screening is recommended in those with chronic liver 
disease . 
LIVER CANCER 
 
 
                                               Fig. No: 6 
           In certain cases ablation therapy, embolization therapy, or liver transplantation, may be 
used. Small lumps in the liver may be simply closely followed.  The word "hepatic" is from 
the Greek hêpar, meaning "liver". 
1.26. SIGNS AND SYMPTOMS 
Signs and symptoms depend on what type of cancer is present : 
The Cholangiocarcinoma is associated with 
 Sweating, 
 Jaundice, 
 Abdominal pain, 
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 Weight loss and liver enlargement. 
 Hepatocellular carcinoma is associated with 
 Abdominal mass,  
 Abdominal pain, 
 Emesis, anemia, 
 Back pain, 
 Jaundice, itching, 
 Weight loss and fever.  
1.27. CAUSES 
VIRUSE INFECTION 
Viral infection with either hepatitis C virus (HCV) or Hepatitis B virus (HBV) 
is the chief cause of liver cancer in the world today, accounting for 80% of hepato 
cellular carcinoma (HCC) The viruses cause HCC because massive inflammation, 
fibrosis and eventual cirrhosis occurs within the liver. HCC usually arises after 
cirrhosis, with an annual incidence of 1.7% in cirrhotic HCV-infected 
individuals
(26)
Around 5-10% of individuals that become infected with HBV become 
chronic carriers, and around 30% of these acquire chronic liver disease, which can 
lead to HCC. HBV infection is also linked to cholangiocarcinoma. The role of viruses 
other than HCV or HBV in liver cancer is much less clear, although there is some 
evidence that co-infection of HBV and hepatitis D virus may increase the risk of 
HCC. 
Many genetic and epigenetic changes are formed in liver cells during HCV 
and HBV infection, which is a major factor in the production of the liver tumors. The 
viruses induce malignant changes in cells by altering gene methylation, affecting gene 
expression and promoting or repressing cellular signal transduction pathways. By 
doing this the viruses can prevent cells from undergoing a programmed form of cell 
death (apoptosis) and promote viral replication and persistence.
 
Viral infection with either hepatitis C virus (HCV) or Hepatitis B virus (HBV) 
is the chief cause of liver cancer in the world today, accounting for 80% of 
hepatocellular carcinoma (HCC).The viruses cause HCC because massive 
inflammation, fibrosis and eventual cirrhosis occurs within the liver. HCC usually 
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arises after cirrhosis, with an annual incidence of 1.7% in cirrhotic HCV-infected 
individuals. Around 5-10% of individuals that become infected with HBV become 
chronic carriers, and around 30% of these acquire chronic liver disease, which can 
lead to HCC. HBV infection is also linked to cholangiocarcinoma. The role of viruses 
other than HCV or HBV in liver cancer is much less clear, although there is some 
evidence that co-infection of HBV and hepatitis D virus may increase the risk of 
HCC.
 (27) 
Many genetic and epigenetic changes are formed in liver cells during HCV and 
HBV infection, which is a major factor in the production of the liver tumors. The 
viruses induce malignant changes in cells by altering gene methylation, affecting gene 
expression and promoting or repressing cellular signal transduction pathways. By 
doing this the viruses can prevent cells from undergoing a programmed form of cell 
death (apoptosis) and promote viral replication and persistence.
 
Aflatoxin exposure can lead to the development of HCC. The aflatoxins are a 
group of chemicals produced by the fungi Aspergillus flavus (the name comes from A. 
flavus toxin) and A. parasiticus. Food contamination by the fungi leads to ingestion of 
the chemicals, which are very toxic to the liver. Common foodstuffs contaminated 
with the toxins are cereals, peanuts and other vegetables. Contamination of food is 
common in Africa, South-East Asia and China. Concurrent HBV infection and 
aflatoxin exposure increases the risk of liver cancer to over three times that seen in 
HBV infected individuals without aflatoxin exposure. The mechanism by which 
aflatoxins cause cancer is through genetic mutation of a gene required for the 
prevention of cancer. 
 
 High grade dysplastic nodules are precancerous lesions of the liver. Within 2 
years, there is a risk of cancer arising from these nodules of 30-40%. 
 Obesity has emerged as an important risk factor as it can lead to 
steatohepatitis. 
 Diabetes increases the risk of HCC. 
 Smoking increases the risk of HCC compared to non-smokers and previous 
smokers. 
 There is around 5-10% lifetime risk of cholangiocarcinoma in people with 
primary sclerosing cholangitis. 
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 Liver fluke infection increases the risk of cholangiocarcinoma, and is the 
reason Thailand has particularly high rates of this cancer.  
1.28. CAUSES IN CHILDREN 
Increased risk of liver cancer in children can be caused by Beckwith 
wiedemann Syndrome. (associated with hepatoblastoma
,(28)
 familial adenomatous 
polyposis (associated with hepatoblastoma), low birth weight (associated with 
hepatoblastoma). Progressive familial intrahepatic cholestasis (associated with HCC) 
and Trisomy (associated with hepatoblastoma) 
.
 (
1.29.BREAST CANCER 
Cancer that develops from breast tissue.  Signs of breast cancer may include a 
lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from 
the nipple, or a red scaly patch of skin.  In those with distant spread of the disease, 
there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin
.
 
Risk factors for developing breast cancer include being female, obesity, lack 
of physical exercise, drinking alcohol, hormone replacement therapy during 
menopause, ionizing radiation, early age at first menstruation, having children late or 
not at all, older age, and family history. About 5–10% of cases are due to genes 
inherited from a person's parents, including BRCA1 and BRCA2  among others. 
Breast cancer most commonly develops in cells from the lining of milk ducts and the 
lobules that supply the ducts with milk. Cancers developing from the ducts are known 
as ductal carcinomas, while those developing from lobules are known as lobular 
carcinomas. In addition, there are more than 18 other sub-types of breast cancer. 
Some cancers, such as ductal carcinoma in situ, develop from pre-invasive lesions
,
 
The diagnosis of breast cancer is confirmed by taking a biopsy of the concerning 
lump. Once the diagnosis is made, further tests are done to determine if the cancer has 
spread beyond the breast . 
The balance of benefits versus harms of breast cancer screening is 
controversial. A 2013 Cochrane review stated that it is unclear if mammographic 
screening does more good or harm. A 2009 review for the US Preventive Services 
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Task Force found evidence of benefit in those 40 to 70 years of age and the 
organization recommends screening every two years in women 50 to 74 years old
(29). 
 
CHANGES  DURING   BREAST CANCER 
 
 
 
Fig. No: 7 
1.30. RISK FACTORS 
Risk factors can be divided into two categories: 
 modifiable risk factors (things that people can change themselves, such as 
consumption of alcoholic beverages), and 
 fixed  risk factors (things that cannot be changed, such as age and biological 
sex). 
 The primary risk factors for breast cancer are being female and older age. 
Other potential risk factors include genetics, lack of childbearing or lack of 
breastfeeding, higher levels of certain hormones 
(31).
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 Smoking tobacco appears to increase the risk of breast cancer, with the greater 
the amount smoked and the earlier in life that smoking began, the higher the 
risk.  
 A number of dietary factors have been linked to the risk for breast cancer. 
Dietary factors which may increase risk include a high fat diet, high alcohol 
intake, and obesity-related high cholesterol levels.  
   1.32.   PROSTATE CANCER 
              It is a cancer that occurs in a man’s prostate  a small walnut shaped that   
produces the seminal fluid that nourishes and transports sperm. Prostate cancer, also 
known as carcinoma of the prostate, is the development of cancer in the prostate, a 
gland in the male reproductive system. Most prostate cancers are slow growing; 
however, some grow relatively quickly. The cancer cells may spread from the prostate 
to other parts of the body, particularly the bones and lymph node. It may initially 
cause no symptoms In later stages it can lead to difficulty urinating, blood in the 
urine, or pain in the pelvis, back or when urinating. A disease known as benign 
prostatic hyperplasia may produce similar symptoms. Other late symptoms may 
include feeling tired due to low levels of red blood cells 
  Prostate-specific antigen  (PSA) testing increases cancer detection but does not 
decrease mortality.The United States Preventive Services Task Force recommends 
against screening using the PSA test, due to the risk of over diagnosis and 
overtreatment, as most cancer diagnosed would remain asymptomatic
. (32). 
Many cases can be safely followed with active surveillance or watchful 
waiting. Other treatments may include a combination of surgery, radiation therapy, 
hormone therapy or chemotherapy.When it only occurs inside the prostate it may be 
curable
 
In those in whom the disease has spread to the bones, pain medications, 
bisphosphonates and targeted therapy, among others, may be useful.  
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STAGES OF PROSTATE CANCER 
 
Fig. No: 8 
1.33. SIGNS AND SYMPTOMS 
 Hematuria (blood in the urine), 
 Dysuria (painful urination) 
 Nocturia (increased urination at night) 
 Leg weakness 
 Bone pain 
 Painful ejaculation 
1.34. RISK FACTORS 
 A complete understanding of the causes of prostate cancer remains elusive. 
The primary risk factors are obesity, age and family history.  
 Prostate cancer is very uncommon in men younger than 45, but becomes more 
common with advancing age. The average age at the time of diagnosis is 70.  
 However, many men never know they have prostate cancer. Autopsy studies 
of Chinese, German, Israeli, Jamaican, Swedish, and Ugandan men who died 
of other causes have found prostate cancer in 30% of men in their fifties, and 
in  
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 80% of men in their seventies.Men who have first-degree family members 
with prostate cancer appear to have double the risk of getting the disease 
compared to men without prostate cancer in the family. 
1.34. OVARIAN CANCER  
It is a cancer that forms in an ovary. It results in abnormal cells that have the 
ability to invade or spread to other parts of the body. When this process begins, there 
may be no or only vague symptoms. Symptoms become more noticeable as the cancer 
progresse
.. 
These symptoms may include bloating, pelvic pain, abdominal swelling, 
and loss of appetite, among other
 (33).
 Common areas to which the cancer may spread 
include the lining of the abdomen  ,lining of the bowel and bladder, lymph nodes, 
lungs ,and liver.
(24)
 
The risk of ovarian cancer increases in women who have ovulated more over 
their lifetime. This includes those who have never had children, those who begin 
ovulation at a younger age or reach menopause at an older age. Other risk factors 
include hormone therapy after menopause, fertility medication, and obesiety. Factors 
that decrease risk include hormonal birth control, tubal ligation, and breast feeding. 
1.35. SIGNS AND SYMPTOMS 
Signs and symptoms of ovarian cancer are: 
 Bloating, 
 Abdomino pelvic pain or discomfort 
 Back pain, 
 Irregular menstruation or postmenopausal 
 Vaginal bleeding, 
 Constipation 
 Urinary symptoms (including frequent urination and urgent urination). 
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1.36. RISK FACTORS 
 Most of the risk for ovarian cancer is related to the amount of time spent in 
ovulation. Thus not having children is a risk factor for ovarian cancer, likely 
because ovulation is suppressed via pregnancy.  
 Things that halt ovulation including breast feeding, oral contraceptive use with 
estrogen/progesterone combination contraceptives, multiple pregnancies, and 
pregnancy at an early age, all decrease risk of ovarian cancer.  
 These conditions decrease the overall time during one's lifetime spent 
ovulating. A positive family history of ovarian cancer is a risk factor for 
ovarian cancer. 
 People with hereditary nonpolyposis colon cancer (Lynch Syndrome), and 
those with BRCA-1 and BRCA-2 genetic abnormalities are at increased risk. 
(25)
. 
1.38. CELL LINES USING IN- VITRO STUDIES 
Cancer cell lines have been widely used for research purposes and proved to 
be a useful tool in the genetic approach, and its characterization shows that they are, 
in fact, an excellent model for the study of the biological mechanisms involved in 
cancer. Examples are shown in Table.1 The use of cancer cell lines allowed an 
increment of the information about the deregulated genes and signalling pathways in 
this disease . Furthermore, the use of the cell model was in the origin of the 
development and testing of anticancer drugs presently used , and in the development 
of new therapies , but also as an alternative to transplantable animal tumours in 
chemotherapeutics testing . In fact, the use of the appropriate in vitro model in cancer 
research is crucial for the investigation of genetic, epigenetic and cellular pathways , 
for the study of proliferation deregulation, apoptosis and cancer progression , to 
define potential molecular markers and for the screening and characterization of 
cancer therapeutics . The results of the research in cancer cell lines are usually 
extrapolated to in vivo human tumours  and its importance as models for drug testing 
and translational study have been recognized by many biomedical and pharmaceutical 
companies.
 (34) 
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                                       Table 1
 
Cancer cell line Species Signs Morphology 
mcf-7 Homo sapiens Breast adenocarcinoma Epithelial 
COLO-205,SW-620 Homo sapiens Colon adenocarcinoma Epithelial 
A549,NCI-H23 Homo sapiens Lung carcinoma Epithelial 
HEP-2 Homo sapiens Hepatocellular carcinoma Epithelial 
OVCAR-5 Homo sapiens Ovarian Carcinoma Lymphoblast 
DU-145 Homo sapiens Prostate adenocarcinoma Epithelial 
 
1.39. CYTOTOXICITY 
     It is the quality of being toxic to cells. Examples of toxic agents are an immune 
cells. or some types of venom, e.g. from the puff adder (Bitis arietans) or brown 
recluse spider (Loxosceles reclusa). 
1.40. CELL PHYSIOLOGY 
Treating cells with the cytotoxic compound can result in a variety of cell fates. 
The cells may undergo necrosis, in which they lose membrane integrity and die 
rapidly as a result of cell lysis. The cells can stop actively growing and dividing (a 
decrease in cell viability), or the cells can activate a genetic program of controlled cell 
death (apoptosis). 
1.41. MEASUREMENT 
Cytotoxicity assays are widely used by the pharmaceutical industry to screen 
for cytotoxicity in compound libraries. Researchers can either look for cytotoxic 
compounds, if they are interested in developing a therapeutic that targets rapidly 
dividing cancer cells, for instance; or they can screen "hits" from initial high-
throughput drug screens for unwanted cytotoxic effects before investing in their 
development as a pharmaceuticals. 
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Assessing cell membrane integrity is one of the most common ways to 
measure cell viability and cytotoxic effects. Compounds that have cytotoxic effects 
often compromise cell membrane integrity. Vital dyes, such as trypan blue or 
propidium iodide are normally excluded from the inside of healthy cells; however, if 
the cell membrane has been compromised, they freely cross the membrane and stain 
intracellular components. 
 
Alternatively, membrane integrity can be assessed by 
monitoring the passage of substances that are normally sequestered inside cells to the 
outside. 
 
1.42. CYTOTOXICITY ASSAY 
 
Fig. No: 10 
 
Cell viability and cytotoxicity assays are used for drug screening and 
cytotoxicity tests of chemicals. indicates various reagents used for cell viability 
detection. They are based on various cell functions such as enzyme activity, cell 
membrane permeability, cell adherence, ATP production, co-enzyme production, and 
nucleotide uptake activity. Many have established methods such as Colony Formation 
method, Crystal Violet method, Tritium-Labeled Thymidine Uptake method, MTT, 
and WST methods, which are used for counting the number of live cells. Trypan Blue 
is a widely used assay for staining dead cells. 
(35).
 
           In this method, cell viability must be determined by counting the unstained 
cells with a microscope or other instruments. However, Trypan Blue staining cannot 
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be used to distinguish between the healthy cells and the cells that are alive but losing 
cell functions. In the Colony Formation method, the number of cell colonies are 
counted using a microscope as a cell viability indicator. In the Tritium-Labeled 
Thymidine Uptake method, [3H]-thymidine is involved in the cell nucleus due to the 
cell growth, and the amount of the tritium in the nucleus is then measured using a 
scintillation counter. Though the Tritiumlabeled thymidine uptake assay is sensitive to 
determine the influence on the DNA polymerization activity, it requires radioisotope 
which causes various concerns. 
The 51Cr method is highly sensitive, and is commonly used to determine low 
levels of cytotoxicity. However, the use of 51Cr also causes problems in handling, 
storage, and disposal of the material. Cellular enzymes such as lactate dehydrogenase, 
adenylate kinase,  
and glucose-6-phosphate dehydrogennase are also used as cell death markers, and 
there are severalproducts available on the market. However, adenylate kinase and 
glucose-6-phosphate are not stable and only lactate dehydrogenase does not lose its 
activity during cell death assays. therefore, cell death assays based on lactate 
dehydrogenase (LDH) activity are more reliable than other enzyme-based cell death 
assays. 
                 Enzyme-based methods using MTT and WST rely on a reductive coloring 
reagent and dehydrogenase in a viable cell to determine cell viability with a 
colorimetric method. This method s far superior to the previously mentioned methods 
because it is easy-to-use, safe, has a high reproducibility, and is widely used in both 
cell viability and cytotoxicity tests. Therefore, this method is suitable for those who 
are just beginning such experiments. Among the enzyme-based assays, the MTT 
assay is the best known method for determining mitochondrial dehydrogenase 
activities in the living cells. In the method, MTT is reduced to a purple formazan by 
NADH. However, MTT formazan is insoluble in water, and it forms purple needle 
shaped crystals in the cells. Therefore prior to measuring the absorbance, an organic 
solvent is required to solubilize the crystals. Additionally, the cytotoxicity of MTT 
formazan makes it difficult to remove cell culture media from the plate wells due to 
floating cells with MTT formazan needles, giving significant well-to-well error. 
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Produce water-soluble formazans and are suitable for cell proliferation and 
cytotoxicity assays. WSTs receives two electrons from viable cells to generate a 
yellow, orange, or purple formazan dye. WST-8, a highly stable WST, is utilized in 
Cell Counting Kit-8 (CCK-8). The electron mediator used in this kit, 1-Methoxy 
PMS, is also highly stable .Therefore, CCK-8 is stable for at least 6 months at the 
room temperature and for one year at 0-5
o
 C. Since WST-8, WST-8 formazan, and 1-
Methoxy PMS have no cytotoxicity in the cell culture media, additional experiments 
may be carried out using the same cells from the previous assay.Dehydrogenase-based 
assays reflect cell conditions with more sensitivity than the other assays because they 
depend on several elements including dehydrogenase, NAD(H), NADP(H), and 
mitochondrial activity.
 
The major difference between CCK-8 and the MTT assay, other than MTT’s 
toxicity, is the enzymes involved. The CCK-8 assay involves most of the 
dehydrogenase in a cell. On the other hand, MTT only involves mitochondrial 
dehydrogenase.  
Therefore, the MTT assay depends on mitochondrial activity, not the cell 
itself. Additionally, CCK-8 is far more sensitive than the MTT assay. Since WST-8 
formazan is water soluble, it does not form crystals like MTT. Therefore, after 1-4 
hours of incubation with the CCK-8 solution, measurement of O.D. at 450 nm gives 
the number of viable cells. No extra steps are required. 
1.43. REAGENTS: 
        DEVICES AND TOOLS 
 Microplate Reader with a 450 - 490 nm filter 
 96 well microplate, sterilized clear plate for cell assay  
 Multi-channel pipette (8 or 12 channel:   10-100 µl) 
 Pipette tips for 10-100 µl 
 CO2 incubator 
 Clean bench 
 Hematocytometer or cell counter 
 Centrifuge and rotor for a( 15 ml centrifuge tube). 
 Cell Counting Kit -8 [product code: CK04] 
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 Cell culture media 
 Material to be tested 
1.44. PROCEDURE & PRECAUTION AND STEPS 
Recover the cells to be assayed from a culture flask.Count the cells and adjust 
the concentration of the cell suspension. (cell concentration: cells/ml)Add 100 µl of a 
cell suspension to each well in a 96 well microplate using serial dilution.Make a well 
of only media to measure thebackground.Incubate for 24-48 hours in a CO2 
incubator. (start time: end time: )Add 10 µl of Cell Counting Kit-8 to each well of the 
96 well microplate. Place in a CO2 incubator for 1-4 hours to react.(start time: end 
time: )Measure the absorbance at 450 nm with a microplate reader. For adherent cells, 
recover the cells using trypsin to detach cells, and use a cell scraper if necessary.Use a 
hematocytometer or a cell counter. 
Be aware that cell number after 24-48 hours of incubation may surpass the 
initial number of cells counted. In order to establish a relationship between cell 
number and absorbance, add the reagent before the cells proliferate, and take a 
reading. When using a plate or petri dish other than a 96 well plate, please add reagent 
equal to 1/10 the media volume. Due to the low volume of reagent added, it is 
recommended to place the pipette tips against the well wall to add the reagent (below 
picture).  
If the reagent sticks to the well wall, tap the plate lightly to mix with the 
media.Since the amount of formazan produced will differ with each cell types, the 
amount of coloration will differ even if the time between adding the reagent and 
taking a reading is the same.  Since bubbles can cause an error, make sure there are no 
bubbles in the each well. If there are bubbles, use a pipette tip to remove or use a 
toothpick to pop them
.
 
SERIAL DILUTION PROCEDURE 
Using an 8 channel multi-pipette, add 100 µl of media to each well of a 96 
well microplate. Next, add 100 µl of a 5 x 105 cells/ml solution to the first well and 
pipette to mix. This well will have the maximum number of cells. Next, take 100 µl 
from the first well and add it to the next well, and mix. The process is repeated as 
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indicated in the figure. Take 100 µl from the last well which contains the minimum 
number of cells and discard.  
1.45. TYPES OF CYTOTOXIC ASSAYS 
 Sulforhodamine B (SRB) assay,  
 One molecule, lactate dehydrogenase (LDH), is commonly measured using 
LDH assay. 
 Cytotoxicity can also be monitored using the 3-(4, 5-Dimethyl-2-thiazolyl)-2, 
5-diphenyl   2H-tetrazolium bromide (MTT) or with 2,3-bis-(2-methoxy-4-
nitro-5-sulfophenyl)-2H-  tetrazolium-5-carboxanilide (XTT), which yields a 
water-soluble product, or the MTS assay 
      OTHER ASSAYS: 
 Clonogenic Assay. 
 WTS Assay. 
1.46. MTT Assay 
The MTT assay is a colorimetric assay for assessing cell metabolic activity. 
NAD(P)H-dependent cellular oxidoreductase enzymes may, under defined conditions, 
reflect the number of viable cells present. These enzymes are capable of reducing the 
tetrazolium dye MTT 3-(4,5-dimethyl  thiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
to its insoluble formazan, which has a purple color. Other closely related tetrazolium 
dyes including XTT, MTS and the WSTs, are used in conjunction with the 
intermediate electron acceptor, 1-methoxy phenazine methosulfate (PMS). With 
WST-1, which is cell-impermeable, reduction occurs outside the cell via plasma 
membrane electron transport. Tetrazolium dye assays can also be used to measure 
cytotoxicity (loss of viable cells) or cytostatic activity (shift from proliferation to 
quiescence) of potential medicinal agents and toxic materials. MTT assays are usually 
done in the dark since the MTT reagent is sensitive to light. 
 
 
CHAPTER1                                                                                        INTRODUCTION 
 
J.K.K.Nattraja College of Pharmacy,Komarpalayam Page 32 
 
SIGNIFICANCE OF MIIT ASSAY 
Tetrazolium dye reduction is dependent on NAD(P)H-dependent 
oxidoreductase enzymes largely in the cytosolic compartment of the cell. Therefore, 
reduction of MTT and other tetrazolium dyes depends on the cellular metabolic 
activity due to NAD(P)H flux. Cells with a low metabolism such as thymocytes and 
splenocytes reduce very little MTT. In contrast, rapidly dividing cells exhibit high 
rates of MTT reduction. It is important to keep in mind that assay conditions can alter 
metabolic activity and thus tetrazolium dye reduction without affecting cell viability. 
In addition, the mechanism of reduction of tetrazolium dyes, i.e. intracellular (MTT, 
MTS) vs. extracellular (WST-1), will also determine the amount of product. 
1.47. CLONOGENIC ASSAY 
       A clonogenic assay is a cell biology technique for studying the effectiveness of 
specific agents on the survival and proliferation of cells. It is frequently used in cancer 
research  laboratories to determine the effect of drugs or radiation on proliferating 
tumor. 
Clonogenic assay or colony formation assay is an in vitro cell survival assay 
based on the ability of a single cell to grow into a colony. The colony is defined to 
consist of at least 50 cells. The assay essentially tests every cell in the population for 
its ability to undergo “unlimited” division. Clonogenic assay is the method of choice 
to determine cell reproductive death after treatment with ionizing radiation, but can 
also be used to determine the effectiveness of other cytotoxic agents. Only a fraction 
of seeded cells retains the capacity to produce colonies. Before or after treatment, 
cells are seeded out in appropriate dilutions to form colonies in 1–3 weeks. Colonies 
are fixed with glutaraldehyde (6.0% v/v), stained with crystal violet (0.5% w/v) and 
counted using a stereomicroscope. A method for the analysis of radiation dose–
survival curves is included. 
Although this technique can provide accurate results, the assay is time-
consuming to set up and analyze and can only provide data on tumor cells that can 
grow in culture. The word "clonogenic" refers to the fact that these cells are clones of 
one another. 
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The experiment involves three major steps: 
1. The treatment is applied to a sample of cells. 
2. The cells are "plated" in a tissue culture vessel and allowed to grow. 
3. The colonies produced are fixed, stained, and counted. 
At the conclusion of the experiment, the percentage of cells that survived the 
treatment is measured. A graphical representation of survival versus drug 
concentration or dose of ionizing radiation is called a cell survival curve. 
For Cell-killing Particle assays, the surviving fraction of cells is used to 
approximate the Poisson Distribution of virus particles amongst cells and therefore 
determine the number of CKPs encountered by each cell. 
Any type of cell could be used in an experiment, but since the goal of these 
experiments in oncological research is the discovery of more effective cancer 
treatments, human tumor cells are a typical choice. The cells either come from 
prepared "cell lines," which have been well-studied and whose general characteristics 
are known, or from a biopsy of a tumor in a patient. The cells are put in petri dishes or 
in plates which contain several circular "wells." Particular numbers of cells are plated 
depending on the experiment; for an experiment involving irradiation it is usual to 
plate larger numbers of cells with increasing dose of radiation. For example, at a dose 
of 0 or 1 gray of radiation, 500 cells might be plated, but at 4 or 5 gray, 2500 might be 
plated, since very large numbers of cells are killed at this level of radiation and the 
effects of the specific treatment would be unobservable. 
Counting the cell colonies is usually done under a microscope and is quite tedious. 
Recently, machines have been developed that use algorithms to analyse images. These 
are either captured by an image scanner or an automated microscope that can 
completely automate the counting process. One such automated machine works by 
accepting certain types of cell plates through a slot (not unlike a CD player), taking a 
photograph, and uploading it to a computer for immediate analysis. Reliable counts 
are available in second. 
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1.50. SRB Cell Cytotoxicity Assay 
        Cell  proliferation, measured  as  total  protein  synthesis,  is  a  very  sensitive  
toxicology marker.  Sulforhodamine  B  (SRB)  is  an  anionic  dye  that  binds  to  
proteins electrostatically. The fixed dye, measured photometrically after 
solubilization, correlates with total protein synthesis rate and therefore with cell 
proliferation.
 (37).
 
      The sulforhodamine B (SRB) assay was developed by Skehan and colleagues to 
measure drug-induced cytotoxicity and cell proliferation for large-scale drug-
screening applications. Its principle is based on the ability of the protein dye 
sulforhodamine B to bind electrostatically and pH dependent on protein basic amino 
acid residues of trichloroacetic acid-fixed cells. Under mild acidic conditions it binds 
to and under mild basic conditions it can be extracted from cells and solubilized for 
measurement.  
 Results of the SRB assay were linear with cell number and cellular protein 
measured at cellular densities ranging from 1 to 200%  of confluence. Its sensitivity is 
comparable with that of several fluorescence assays and superior to that of Lowry or 
Bradford. The signal-to-noise ratio is favorable and the resolution is 1000-2000 
cells/well. It performed similarly compared to other cytotoxicity assays such as MTT 
or clonogenic assay. The SRB assay possesses a colorimetric end point and is 
nondestructive and indefinitely stable. These practical advances make the SRB assay 
an appropriate and sensitive assay to measure drug-induced cytotoxicity even at large-
scale application. 
  SRB cell cytotoxicity .Assay is an accurate and reproducible assay based upon 
the quantitative staining of cellular proteins by sulforhodamine B(SRB).This assay 
has been used for high- through out drug screening at the National Cancer Institute 
(NC).Sulforhodamine B is an anionic aminoxanthane dye that forms an electrostatic 
complex with the basic amino acid residues of proteins under moderately acid 
conditions, which provides a sensitive linear response.The colour development is 
rapid and stable and is readily measured at absorbance betweebn 560 and 580 nm.The 
kit components are sufficient for performing up to 1000 assays. 
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    The sulforhodamine B (SRB) assay is used for cell density determination, based on 
the measurement of cellular protein content. The method described here has been 
optimized for the toxicity screening of compounds to adherent cells in a 96-well 
format. After an incubation period, cell monolayers are fixed with 10% (wt/vol) 
trichloroacetic acid and stained for 30 min, after which the excess dye is removed by 
washing repeatedly with 1% (vol/vol) acetic acid. The protein-bound dye is dissolved 
in 10 mM Tris base solution for OD determination at 510 nm using a microplate 
reader. 
The results are linear over a 20-fold range of cell numbers and the sensitivity 
is comparable to those of fluorometric methods. The method not only allows a large 
number of samples to be tested within a few days, but also requires only simple 
equipment and inexpensive reagents. The SRB assay is therefore an efficient and 
highly cost-effective method for screening. 
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2. LITERATURE REVIEW 
2. 1. ANTIOXIDANT AND ANTI CANCER PROPERTIES OF ETHANOLIC 
EXTRACT OF ABUTILON INDICUM. 
    Srikanth P, Karthik PS and etal., Translational Research   Institute   of 
Molecular Sciences Pvt.Ltd (TRIMS LABS, 2-35-72). 
      Successful plant remedies and their preparations as medicinal treatments have 
been used for thousands of years in indigenous cultures around the world. 
       Many of today’s valuable drugs such as asprin, digitoxin, morphine and quinine 
are resulted from traditionally used plants after scientific evaluation. In the present 
study medicinal plants namely Abutilon indicum  and Blumea mollis were chosen to 
screen for potential anti-oxidant properties and cytotoxic activity. The concentration 
of phenol was determined using Folin-Ciocalteu assay (20) with minor modifications. 
The extract was also screened to assess the antioxidant activity using FRAP,  1, 1-
Diphenyl-2-picrylhydryzyl [DPPH] radical scavenging activity and Nitric Oxide 
radical inhibition estimated by the use of Griess Illosvoy reaction  with slight 
modification. 
These extracts show anti-oxidant properties as well as inhibitory effect on 
cancer cells with the increased concentration and duration. When used in higher 
concentrations, these extracts show good inhibition rates which might prove to be 
effective for the prevention of cancer. 
 
2.2.EVALUATING THE ANTIOXIDANT ACTIVITIES IN THE LEAF 
EXTRACT OF A MEDICINAL PLANT, ABUTILON INDICUM (LINN.) 
SWEET . 
Mrinmoy Ghosh, .S. J. Sahani, K.K. Pulicherla . Department of 
Biotechnology,Acharya Nagarjuna University,Nagarjuna Nagar, Guntur- 
522510, Andhra Pradesh, India. 
          
 The plant kingdom is the treasury of pharmaceutically important components. 
The secondary metabolites from plants can play an important role in disease healing, 
used to restore health and also given  the  lead structures for the development of 
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synthetic molecules. The plant species Abutilon indicum (Linn.) belongs to family 
Malvaceae, commonly known  
as Khangi in  India, Country Mallow  in  English  and Atibala  in  Sanskrit. Various  
parts  of  this  plant  are  traditionally  used  to  treat inflammation,  piles,  and  
gonorrhea  and  as  an  immune  stimulant,  antheliminthic,  anti  diabetic,  nervine  
tonic  etc.  The present work  is  focused on protein profiling  and  also  analyzing  the  
antioxidant  activity  including  superoxide dismutase (SOD), Catalase  (CAT) and 
Peroxidase  (PX)  (Guaiacol units)  from  the  leaves of A.  indicum. The  report  has  
shown  that total 12.5±3.6mg of protein was  found per gm of  fresh  leaves. The data  
from native gel  analysis has clearly  shown  the antioxidant activity of A. indicum 
leaves.  
 
2.3. ANTICANCER ACTIVITY OF SYNTHESIZED NANOPARTICLES OF 
ABUTILON INDICUM LEAF. 
B. Ramesh*1 and R. Rajeshwari 2 1*Department of Biochemistry, PSG College 
of Arts and Science, Coimbatore, Tamil Nadu, India.  
 
The  present  study  was  conducted  to  evaluate  the  in-vitro  anticancer  
activity  of  green  synthesized nanoparticles  of  Abutilon  indicum  L.  leaf  extract  
using MCF-7  breast  cancer  cell  line.  The  shade  dried leaves of Abutilon indicum 
L. was subjected to cold maceration with water and the extract utilized for green 
synthesis of silver nanoparticles. The UV-visible spectral analysis indicated the 
formation of nanoparticles, which were characterized by FTI spectroscopy, SEM, 
TEM and EDX analysis. The  in-vitro antioxidant activities  of  the  synthesized 
nanoparticles  were  studied  by  DPPH  radical  scavenging  activity  and  the 
anticancer  activity  by MTT  assay  in MCF-7  breast  cancer  cell  line.  The  study  
indicated  that  the  green synthesized  silver  nanoparticles  of  Abutilon  indicum  L.  
Leaf extract possess  antioxidant  and  anticancer activities. 
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2.4. ANTIULCER ACTIVITY OF METHANOL EXTRACT OF ABUTILON 
INDICUM LEAVES. 
N. L. Dashputre1*, N. S. Naikwade21 Department of Pharmacology, Bhujbal 
Knowledge city, MET’s Institute of Pharmacy, Adgaon, Nashik-422003, India 2 
,Department of Pharmacology, Appasaheb Birnale College of Pharmacy, South 
Shivaji Nagar, Shivaji University, Sangli- 416416, India. 
 
Gastric ulcer is one of the most prevalent gastrointestinal disorders, which 
affects approximately 5-10% of people during their  life.  In  recent  years,  abundant 
work  has  been  carried  out  on  herbal medicine  to  clarify  their  potential  efficacy  
in gastric ulcer prevention or management. Here, present study was carried out  to  
investigate antiulcer activity of methanol extract of Abutilon indicum L. (Family: 
Malvaceae)  leaves in pylorus ligated and ethanol  induced ulceration in  the albino 
rats. Preliminary methanol  extract  of A.  indicum was  subjected  to  the  acute  oral  
toxicity  study  according  to  the OECD . 
guideline no. 425. Based on which, two dose levels i.e. 250 and 500 mg/kg were 
selected for the further study. In pylorus ligation induced ulcer model, various 
parameters were studied viz. gastric volume, pH, total acidity, free acidity, and ulcer 
index. Ulcer  index and percentage  inhibition of ulceration was determined  for 
ethanol  induced ulcer model. Ranitidine at 50  mg/kg  was  used  as  the  standard  
drug.  Pretreatment  of  methanol  extract  of  A.  indicum leaves  showed  significant 
(P<0.05) decrease in  the gastric volume, total acidity and free acidity. However, pH 
of the gastric  juice was significantly (P<0.05) increased only at higher dose, 500 
mg/kg. It showed also significant (P<0.05) decrease in number of ulcers and ulcer  
score  index  in  pylorus  ligation  and  ethanol  induced ulceration models. The 
methanol extract of A.  indicum leaves possess  significant antiulcer properties  in  a 
dose dependent manner.  In conclusion  the  antiulcer properties of  the  extract may 
be attributed  to the presence of phytochemicals like flavonoids (quercetin), alkaloids 
and tannins present in the plant extract with various biological activities. 
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2.5. ANTI-DIABETIC AND ANALGESIC ACTIVITY OF LEAVES OF 
ABUTILON INDICUM 
        D. M. Sarkar, U. M. Sankar, N. M. Mahajan , Andra pradhesh, India. 
The leaves of Abutilon indicum Linn. were traditionally used to treat 
bronchitis, gonorrhoea, and as mouthwash in toothache, etc. The plant of Abutilon 
indicum is available in reach source at Melghat tiger reserve forest area. The tribal 
community living in-the Melghat forest used abudlon indicum leaves to control 
diabetes mellitus. Hence, the present study was planned to verify this claim and also 
to screen for the analgesic property. In addition, an attempt was made to identify the 
class of phytochemicals present in the leaves and also attribute the pharmacological 
property of the leaves to the particular type of phytochemicals. The results revealed 
that the leaves contain steroids, sapogenins, carbohydrates and flavonoids. It was also 
observed that different extracts have shown significant hypoglycemic activity at 400 
mg/kg dose, but aqueous extract was most potent in reducing the blood glucose levels. 
Similarly petroleum ether extract and benzene extract were found to possess very 
good analgesic property. In addition all the extracts have shown CNS depressant 
activity. The results revealed that the use of leaves in controlling diabetes mellitus is 
justifiable.  
2.6.  IN-VITRO ANTI-ARTHRITIC ACTIVITY OF ABUTILON INDICUM 
(LINN.) SWEET  .        
        Mr. Vallabh Deshpande*, Dr. (Mrs.) Varsha M.Jadhav, Dr.V.J.Kadam. 
*Bharati Vidhyapeeth College of Pharmacy, Navi Mumbai, Sector 8, CBD 
Belapur.Maharastra,   India. 
Rheumatoid arthritis is a major ailment among rheumatic disorders. A large 
number of herbal extracts are in vogue used for treatment of various types of 
rheumatic disorders. Abutilon indicum (Linn.) Sweet, an Indian herb was reported to 
have anti-inflammatory as well as analgesic activity, in-vitro as well as in-vivo. The 
present study deals with anti-arthritic activity in-vitro. Various in-vitro anti-arthritic 
pharmacological models were studied, such as, inhibition of protein denaturation, 
effect of membrane stabilization, and proteinase inhibitory action.Herbal extract (aq.) 
with two different concentrations (100mcg/ml and 250mcg/ml.) was used and results 
CHAPTER 2                                                                       LITERATURE REVIEW 
 
 
J.K.K.Nattraja College of Pharmacy,Komarpalayam Page 40 
 
were compared with acetyl salicylic acid (250mcg/ml.). The herbal extract showed 
dose dependent activity which was found to be better than that of acetyl salicylic acid. 
   2.7. FREE RADICAL SCAVENGING ACTIVITY OF ABUTILON  
INDICUM (LINN)   SWEET STEM EXTRACTS. 
  Guno Sindhu Chakraborthy1, Prashant M Ghorpade Svkm’s, Nmims, School 
of   Pharmacy and Technology Management, Shirpur Campus, Dist Dhulia, 
Shirpur, Maharashtra India. 
Currently, there has been an increased interest globally to identify antioxidant 
compounds that are pharmacologically potent and have low or no side effects for use 
in preventive medicine. Antioxidant compounds in food play an important role as a 
health-protecting factor and it neutralizes the free radicals, which are unstable 
molecules and are linked with the development of a number of degenerative diseases 
and conditions including hepatic disease, immune dysfunction, cataracts and macular 
degeneration. Scientific evidence suggests that antioxidants reduce the risk for 
chronic diseases and conditions. 
Antioxidant compounds like phenolic acids, polyphenols and flavonoids 
scavenge free radicals such as peroxide; hydro-peroxide or lipid peroxyl which are 
thereby involved in reducing the risk of diseases associated with oxidative stress. 
Thus in the present study an attempt was made to determination the Total 
Phenolic Content (TPC), quantified by Folin– Ciocalteu method and free radical 
scavenging (antioxidant) activity by DPPH (2, 2-diphenyl-1 picryl hydrazyl) in 
methanolic (AIM) , Hydro-alcoholic (AIHA) and aqueous (AIA) extracts of the 
Abutilon indicum Stem. The TPC and percentage inhibition of DPPH radical were 
calculated and respectively. Thus it could be concluded that the AIA showed a potent 
total phenolic content and possessed a significant scavenging activity. 
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2. 8.  ANTIBIOTIC ACTIVITY OF VARIOUS EXTRACTS OF ABUTILO  
INDICUM LINN. AGAINAST  VARIOUS  PATHOGENS. 
Saravanan R., and etal.,. Department of Pharmaceutical Biotechnology, QIS 
College of Pharmacy,  Vengamukkapalam, Ongole, Andhra Pradesh, India- 523 
272. 
Most  of  the  lethal  diseases  in  the world  are mainly  due  to  bacterial 
infections. There are various herbal drugs and allopathic drugs used as Bactericidal  as  
well  as  Bacteristatic.  Allopathic  drugs  are  relatively more  toxic and explored  to 
produce various side effects. Herbal drugs have  some  advantages  regarding  toxic  
effects  over  allopathic  drugs. Present  study  is  to  evaluate antibiotic activity of 
ethanolic extracts of the  leaves and roots of Abutilon  indium Linn. against various 
harmful bacteria.  Abutilon  indicum  Linn.  is  annual  spreading  herb  and  is 
distributed  in  plains  and  wetlands  of  Bangladesh,  India,  Pakistan, Srilanka. 
The  roots,  bark,  leaves  and  seeds  of  this  plant  are  having medicinal  
properties.  Different  concentrations  of  ethanolic  extracts such as 10μg/ml, 
50μg/ml, 100μg/ml and 150μg/ml were prepared and antibiotic activity was found by 
cup plate method. 
2.9. IN VITRO ANTI SNAKE VENOM POTENTIAL OF ABUTILON 
INDICUM LINN LEAF EXTRACTS   AGAINST ECHIS CARINATUS  
(INDIAN SAW SCALED VIPER).  
Vineetha M. Shrikanth, and etal., Tamil Nadu, India. 
 Envenomings  by  snake  bite  involves  medical  emergencies  and  its  
clinical  management  is  by  the administration of antivenom. The antivenom/antisera  
induce early or  late adverse  reactions.  In  this  regard, the plant  kingdom  is  
explored  to minimize  the  side  effects. The  present  study  evaluates  the  in  vitro  
anti venom potential of Abutilon indicum leaves extract against Echis carinatus (Saw 
Scaled Viper) venom. The leaf  extracts  of  A.  indicum  were  used  to  evaluate  the  
enzyme  inhibiting  activity  of  protease, phosphomonoesterase,  phosphodiesterase,  
acetylcholinesterase,  phospholipase  A2,  hyaluronidase  and  L-amino acid oxidase 
toxic enzymes present in snake venom. The methanolic extract  inhibited the activity 
of all enzymes present in the venom. The extract showed promising results in 
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inhibiting enzymes and would be further confirmed by in vivo and pharmacological 
studies.   
2.10. EVALUATION OF ANTI-INFLAMMATORY AND ANTI-
PROLIFERATIVE ACTIVITY OF ABUTILON INDICUM L. PLANT 
ETHANOLIC LEAF EXTRACT ON LUNG CANCER CELL LINE A549 FOR 
SYSTEM NETWORK STUDIES. 
Kaladha.D. Department of Biochemistry/Bioinformatics, GITAM University, 
Visakhapatnam, India 2Department of Biochemistry, Dr Lankapalli Bullayya P 
G College, Visakhapatnam, India. 
Pharmaceutically important components in medicinal plant kingdom are useful 
to control and cure many diseases like lung cancer. In the present study, an evaluation 
was performed to know the anti-inflammatory and anti-proliferative activity of 
ethanolic leaf extract of Abutilon indicum for potential chemopreventive agent against 
lung cancer. Experimentation is also conducted on lung cancer cell line A549 along 
with interaction studies of Apaf- 1 gene. The ethanolic leaf extract of A. indicum is 
showing good anti-inflammatory activity (IC50: 8.89 µg/mL) based on 5-
Lipoxygenase (5-LOX) inhibition assay. The standard compound, Curcumin has 
shown IC50 as 8.14 µg/mL based on study. The ethanolic leaf extract of A.indicum 
has also shown good response on human Caucasian lung carcinoma of A549 cell line 
(IC50: 85.2 µg/mL) shows anti-proliferative activity. Further analysis has also shown 
the interaction of proteins that are involved in inflammatory and cancer response. 
Apoptosis-activating factor, Apaf- 1 gene increases the sensitivity of A549 cell line 
through interaction with proteins like CASP9, CASP3, CYCS, BCL2L1, TP53, 
BCL2, CASP8, HSPA4, DIABLO and CASP7. The experimental work concludes that 
bioactive components present in the ethanolic leaf extract of A.indicum shows good 
anti-inflammatory and anti-proliferative activity by inducing Apaf-1 through CASP9, 
CASP3, CYCS, BCL2L1, TP53, BCL2, CASP8, HSPA4, DIABLO and CASP7 
network. 
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2.11. PHARMACOGNOSTICAL EVALUATION AND ANTICONVULSANT 
ACTIVITY OF STEM OF ABUTILON INDICUM LINN SWEET. 
 
MAHANTHESH M. C., JALALPURE S. S. Bhagwant University, Ajmer, 
Rajasthan, India, Tatyasaheb Kore College of Pharmacy, Warananagar 416113, 
Maharashtra, India, Department of Pharmacognosy, KLE’S Collegeof 
Pharmacy and Dr. Prabhakar Kore Basic Science Research Centre, KLE 
University,Belgaum-10, Karnataka, India. 
 
To investigate the pharmacognostical characteristics and in vivo 
anticonvulsant activity of chloroform, ethanol (90%) and aqueous extracts of Abutilon 
indicum Linn sweet stem. 
  The Abutilon indicum Linn sweet stem were successively extracted using 
chloroform, ethanol and aqueous solvent (water). The extracts were screened for 
phytochemicals using HPTLC and GC-MS techniques. The extracts were also 
screened for acute toxicity and anticonvulsant activity, against MES and PTZ induced 
convulsions, using Wistar albino rats. 
 The phytochemical screening study reveals the presence of more chemical 
constituents in chloroform extract followed by ethanol and aqueous extract. We found 
no significant changes in average body weight of animals, up to tested oral dose of 
3000 mg/kg, during acute toxicity study. The in vivo study reveals the anticonvulsant 
activity of chloroform and ethanol extract against MES and PTZ induced convulsions. 
The chloroform extract is found to be more potent, similar to Phenytoin, in controlling 
both MES and PTZ induced convulsions than ethanol and aqueous extracts. 
 The results obtained suggest that the chloroform extract of Abutilon indicum 
stem has remarkable anticonvulsant activity. Also, our study indicates the potential 
application of Abutilon indicum stems in the treatment of convulsive disorders as a 
need of modern health science. However, the further studies are needed to screen the 
active constituent having an anticonvulsant effect. 
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2.12. ANTIBACTERIAL AND ANTIFUNGAL ACTIVITIES OF BARK AND 
ROOT EXTRACT FROM ABUTILON INDICUM (L.) SWEET . 
D. Saranya, J. Sekar* and G. Adaikala Raj  
Department of Botany, Annamalai University, Annamalai Nagar - 608 002, 
Tamil Nadu, India. 
In the present investigation, antibacterial and antifungal activities of Abutilon 
indicum bark and root extracts  was  studied.  A.  indicum  bark  and  root  was  
extracted  successively  with  different  solvents  viz., petroleum ether, chloroform, 
ethyl acetate and methanol. Solvent extracts were screened for its antimicrobial 
activity  against  bacterial  strains  such  as  Staphylococcus  aureus,  Streptococcus  
pyogenes,  Enterococcus  faecalis, Escherichia coli, Proteus vulgaris, Pseudomonas 
aeruginosa, Vibrio cholerae, Candida albicans, Candida parapsilosis  and Candida  
tropicalis  by  using  the  extent  of  the  inhibitory  zone,  determination  of Minimum  
Inhibitory  Concentration  (MIC),  Minimum  Bactericidal  Concentration  (MBC)  
and  Minimum  Fungicidal  Concentration  (MFC).  The  screening of  ethyl  acetate  
extracts  of  bark  and  root  of  A.  indicum showed the highest antibacterial activity 
against Staphylococcus aureus and the mean zone of inhibition was  15.3 mm. The 
lowest MIC (125 and 125 μg/ml), MBC (250 and 1000 μg/ml) and MFC values (250 
and 1000 µg/ml) were  recorded. The  bark  ethyl  acetate  extracts  contained  strong  
phytochemicals  such  as  flavonoids, steroids, phenolic compounds and  tannins. 
Finally concluded  that Abutilon  indicum has antimicrobial activity and the ethyl 
acetate bark and root are useful sources of antimicrobial agents and for further 
pharmacological studies towards bacterial and fungal infections. 
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3. SCOPE AND PLAN OF WORK 
Herbs are preferred  because they do not produce any adverse effect with respect 
to their popularity and therapeutic utility. There is evidence of herbs having been used 
in the treatment of various diseases. Hence Abutilon Idicum is selected for the present 
investigation on in vitro antitumor activity
(38).
 
 Collectin and Authentication of Abutilon Inicum. 
 Shade drying and Pulverization 
3.1. PHYTOCHEMICAL STUDIES OF ABUTILON  INDICUM 
 Extraction of  Plant Material 
 Preliminary Phytochemical Screening of  Extracts. 
3.2. Extraction of Plant Material 
    Successive solvent extraction of air dried leaves of Abutilon Indicum by using the 
solvents like  
 Methanol 
 Aqueous 
3.3. PHARMACOLOGICAL STUDIES 
 SRB Cell Cytotoxicity Assay. 
 In Vitro anti tumor activity in human cancer cell lines. 
 
3.4. RESULTS & DISCUSSION 
 
3.5. CONCLUSION 
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4. PLANT PROFILE 
 
Fig. No: 11 
4.1.BOTANICAL DESCRIPTION 
 ABOUT ABUTILON INDICUM PLANT 
Abutilon indicum is a small shrub in the Malvaceae family, native to tropic and 
subtropical regions and sometimes cultivated as an ornamental. This plant is often 
used as a medicinal plant and is considered invasive on certain tropical islands It is 
known as “Atibala” in Hindi and found in the outer  Himalayan  tracts  from  Jammu  
to  Bhutan  up  to  an  altitude  of  1500m  and  extending through the whole of 
northern and central India.
(31)
   
 Botanical Name :   Abutilon indicum (L.) Sweet. 
 Synonyms :  Sida asiatica L. 
 Plant Family : Malvacea. 
 Plant Form : Shrub. 
 Common Names :  
  English :  Kanski, Indian Mallow, Country Mallow.  
 Hindi : Kanghi. 
 Marathi: Petari. 
 Tamil : Paniyaratutti 
 Malayalam : Velluram 
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 Telugu : Tuturbenda 
 Kannada : Tutti. 
 Bengali : Potari. 
4.2.PHYTOCHEMICAL CONSTITUENTS 
The  whole  plant  contains  mucilaginous  substances  and asparagines.  
saponins,  flavonoids,  alkaloids,  hexoses,  n-alkane  mixtures  (C22-34),  alkanol  as  
main  classes  of compounds. Some important constituents reported in the plant  are  
β-sitosterol,  vanillic  acid,  p-coumaric  acid, caffeic  acid,  fumaric  acid,  Abutilon  
A,(R)-N-(1’-methoxycarbonyl-2’phenylethyl)-4-hydroxybenzamide, hydroxybenzoic,  
galacturonic,  p Dglycosyloxybenzoic and amino acids The plant Abutilon indicum 
contains of essential oil which mainly consists of α-pinene -caryophyllene, 
caryophyllene oxide,  endesmol,  farnesol,  borenol,  geraniol,  geranyl acetate, 
elemene and α-cineole. 
4.3.NATURAL HOME REMEDIES WITH ABUTILON INDICUM 
Abutilon Indicum has many health benefits ranging from elimination of thread 
worms to colds and fevers. Abutilon indicum benefits also include treating piles and 
the symptoms of tuberculosis. It is sweet and cooling herb.
 (33)
 
 Its antibacterial properties help to treat all kinds of wounds. Grind the leaves 
of the herb with a little turmeric and apply on wounds to treat inflammation, 
pain and infection 
 The seeds are used to help alleviate the symptoms of diarrhoea and to rid the 
body of thread worms. Seeds are crushed  and then simmered in water to make 
a tea. It also cures irritants that can cause diarrhoea. 
 It has also  been used traditionally as a home remedy to treat colds and fever. 
The part of the plant that is above the ground are simmered to produce an 
infusion. This is said to relieve when consumed several times each day. 
 Another home remedy for tooth ache and  gums are as follows : Make a 
decoction boiling the leaves in water with little alum . Gargle with this 
decoction. 
 Its health benefits includes its being used as a drug to stimulate intestinal 
secretions. 
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5. METHODOLOGY 
5.1. PHYTOCHEMISTRY 
Abutilon  indicum  has  been  explored  phytochemically  by various  
researchers  and  found  to  possess  number  of chemical constituents.   
5.2.WHOLE PLANT   
The  whole  plant  contains  mucilaginous  substances  and asparagines.  
saponins,  flavonoids,  alkaloids,  hexoses,  n-alkane  mixtures  (C22-34),  alkanol  as  
main  classes  of compounds. Some important constituents reported in the plant  are  
β-sitosterol,  vanillic  acid,  p-coumaric  acid, caffeic  acid,  fumaric  acid,  Abutilon  
A,(R)-N-(1’-methoxycarbonyl-2’phenylethyl)-4-hydroxybenzamide,hydroxybenzoic,  
galacturonic,  p Dglycosyloxybenzoic and amino acids The plant Abutilon indicum 
contains of essential oil which mainly consists of α-pinene -caryophyllene, 
caryophyllene oxide,  endesmol,  farnesol,  borenol,  geraniol,  geranyl acetate, 
elemene and α-cineole. (38). 
5.3. ROOT   
From the roots, non – drying oil consisting of various fatty acids  viz.  linoleic,  
oleic,  stearic,  palmitic,  lauric, myristic, caprylic, capric and unusual  fatty acid 
having C17 carbon skeleton,  sitosterol,  and  amyrin  from  unsaponifiable matter 
were yielded 
5.4. LEAVES   
The  leaves  of  the  plant  contain  steroids,  sapogenins, carbohydrates  and  
flavonoids[20.  Eudesmic  acid,  ferulic acid  and  caffeic  acid  have  been  isolated  
from  the methanol extract of  leaves of the plant Abutilon  indicum. IR,  1H-NMR,  
13C-NMR, mass  spectroscopy  and  chemical methods  allowed  the  identification  
of  these compounds.[21  Flavonoids,  Terpenes, Amino  acids, Aldehyde,  
Hydrocarbon,  Ketone,  Fatty  acids  and  esters were  reported  for  the  first  time  
from  the  ethanolic  leaf extract of Abutilon  indicum by using gas chromatography22 
coupled to mass spectrometry (GC-MS) . 
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5.5.  FLOWER   
Seven  flavonoids  compounds:  luteolin,  chrysoeriol, luteolin  7-O-beta-
glucopyranoside,  chrysoeriol  7-O-beta-glucopyranoside,  apigenin  7-O-beta-
glucopyranoside, quercetin  3-O-beta-glucopyranoside,  quercetin  3-O-alpha-
rhamnopyranosyl  (1  -->  6)-beta-glucopyranoside, were isolated and identified from 
the flowers of Abutilon indicum  (L.)  Sweet  (Malvaceae). Two  sesquiterpene 
lactones i.e. alantolatone and isoalantolactone have been first time reported. 
5.6. FRUITS  
Fruits contain flavonoids and alkaloids.  
5.7. SEED   
A  water  soluble  galactomannan  has  been  isolated  from the seeds of 
Abutilon indicum containing  -galactose and -mannose in 2:3 molar ratio 26 the seed 
oil of the plant. (36) 
5.8. PLANT COLLECTION: 
PLANT COLLECTION & AUTHENTICATION 
           Large numbers of plants of  Abutilon Indicum  were  collected from the  village 
of Thirunelveli Tamil nadu. The plant was identified by Dr.V.Chelladurai Research 
officer-Botany(Scientist-C),Central council for research in Ayurveda and siddha,Govt 
of india (RETIRED). 
5.9. PROCESSING OF PLANT MATERIAL :- 
             The leaf extracts of the plant under study were obtained using the Soxhlet 
Extraction Method. A Soxhlet Extractor was used for this purpose. 
(55)
 A Soxhlet 
extractor is a piece of laboratory apparatus invented in 1879 by Franz von Soxhlet.
 (56)
 
The soxhlet extraction of leaves was carried out by using following procedure; 50 
grams of whole plant washed and dried were taken and placed in a thimble made up 
from thick filter paper, which was loaded into the main chamber of the Soxhlet 
extractor. The Soxhlet extractor was placed onto a round bottom flask containing the 
extraction solvent i.e. distilled water. The Soxhlet was then equipped with a 
condenser. The solvent was heated at 90 to reflux: As the solvent vapour travelled up 
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a distillation arm, into a condenser, the condensed vapours dripped back down into 
the chamber housing the solid material. The chamber containing the solid material 
slowly filled up with warm solvent. When the Soxhlet chamber was almost full, the 
chamber was automatically emptied by a siphon side arm, with the solvent running 
back down to the distillation flask. This cycle was allowed to repeat 18 times. After 
extraction the solvent was removed, by means of a rotary evaporator. The extracted 
compound was collected. The non-soluble portion of the extracted solid in the thimble 
was discarded. The aqueous extract was then used for further investigation. Similarly 
methanolic extract was also obtained by using Soxhlet extraction method
.(39) 
 
 
SOXHLET APPARATUS 
 
Fig. No: 15 
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5.10. PHYTOCHEMICAL SCREENING OF WHOLE PLANT OF AQUEOUS 
AND METHANOLIC EXTRACT OF ABUTILON INDICUM. 
5.11. PHYTOCHEMICAL ANALYSIS 
              Extract were tested for the presence of active principle such as Triterpenoids, 
Steroids, Glycosides, Saponins, Alkaloid, Flavonoids, Tannins,   Proteins, Free 
Amino Acid, Carbohydrate and lignin. Following standard procedures were use. 
5.12. TEST FOR STEROIDS AND TRITERPENOIDS: 
              Liebermann Bur chard test – Crude extract was mixed with few drops of 
acetic anhydride, boiled and cooled. Concentrated sulphuric acid was then added from 
the sides of the test tube and observed for the formation of a brown ring at the 
junction of two layers. Green coloration of the upper layer and the formation of deep 
red colour in the lower layer would indicate a positive test for steroid and 
triterpenoids respectively. 
5.13.TEST FOR GLYCOSIDES: 
              Keller killiani test – Test solution was treated with few drops of glacial acetic 
acid and ferric chloride solution and mixed. Concentration sulphuric acid was added 
and observed for the formation of two layers. Lower reddish brown layer and upper 
acetic acid layer which turns bluish green would indicated a positive test for 
glycosides. 
               Bromine water test – Test solution was dissolved in bromine water and 
observed for the formation of yellow precipitate to show a positive result for the 
presence of glycosides. 
5.14.TEST FOR SAPONINS : 
               Foam Test – Test solution was mixed with water and shaken and observed 
for the formation of froth, which is stable for 15 minutes for a possible result. 
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5.15.TEST FOR ALKALOIDS: 
                Hager’s Test –Test solution was treated with few drops of Hanger’s reagent 
(saturated picric acid solution). Formation of yellow precipitate would show a positive 
result for the presence of alkaloids. 
5.16.TEST FOR FLAVONOIDS: 
               Ferric chloride test - Test solution when treated with few drops of ferric 
chloride solution would result in the formation of blackish red colour indicating the 
presence of Flavonoids. 
               Alkaline reagent Test – Test solution when treated with sodium hydroxide 
solution, shows increase in the intensity of yellow colour which would become 
colourless on addition of few drops of dilute hydrochloric acid, indicates the presence 
of Flavonoids. 
               Lead acetate solution Test – Test solution when treated with few drops of 
lead acetate (10%) solution would result in the formation of yellow precipitate. 
5.17.TEST FOR TANNINS: 
               Gelatine Test – Test solution when treated with gelatine solution would 
given white precipitate indicating the presence of tannins. 
5.18.TEST FOR PROTEINS: 
                Biuret Test – Test solution was treated with 10% sodium hydroxide solution 
and two drops of 0.1% copper sulphate solution and observed for the formation of 
violet/pink colour. 
5.19.TEST FOR FREE AMINO ACIDS: 
               Ninhydrin Test – Test solution when boiled with 0.2% solution of 
Ninhydrin, would result in the formation of purple colour suggesting the presence of 
free amino acids. 
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5.20.TEST FOR CARBOHYDRATE: 
                Benedict’s test –Test solution was mixed with few drops Benedict’s reagent 
(alkaline solution containing cupric citrate complex) and boiled in water bath, 
observed for the formation of reddish brown precipitate to show a positive result for 
the presence of carbohydrate
18
. 
5.21. PHYSIO CHEMICAL EVALUATION.  
Table No : 2 
 
S.NO 
 
Standardization 
parameters 
 
% W/W 
 
1. 
 
Total Ash 
 
24.08 
 
2. 
 
Acid insoluable ash 
 
5.3 
 
3. 
 
Water soluble ash 
 
6.55 
 
4. 
 
Loss on drying 
 
0.3 
 
5.22. EXTRACTIVE VALUES. 
Table No. 3 
 
S.No. 
 
EXTRACTS 
 
EXTRACTABILITY 
( %) 
 
1. 
 
Aqueous 
 
20 % 
 
2. 
 
Methanol 
 
8.2 % 
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 5.23. PHARMACOLOGICAL ACTIVITIES. 
    5.24. ANTI-TUMOUR ACTIVITY 
    5.25.  IN-VITRO Studies using cell lines and Cultures: 
    5.26 .CELL LINES AND CULTURES. 
 Breast [mcf-7,2R-75-1] 
 Colon [colo-205,sw-620] 
 Lung [A-549,NCI-H23] 
 Liver [HEP-2]. 
 Ovary [OVCAR-5], 
 prostate[DU-145]. 
 
5.27. PREPARATION OF CONTROL. 
 Adriamycin   
 5,fluorourocil 
 Mitomycin C                                  
 in DMSO[ Dimethyl sulphoxide]. 
 
 
 Diluted in to gentamycin medium to obtain deseried concentration {2×10-5  
and 2*10
4
m}. 
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5.28. PHARMACOLOGICAL ASSESMENT OF ANTI-TUMOUR ACTIVITY 
USING SRB ASSAY. 
 
 
Fig. No: 16 
 
 Sulforhodamine B Is an anionic aminoxanthene dye that forms an electrostatic 
complex with the basic amino acid residues of proteins under moderately acid 
conditions, which provides as sensitive linear response. The color development is 
rapid and stable and is readily measured at absorbances between 560 and 580mm. The 
kit components are sufficient for performing up to 1000 assays. 
(38)
 
 
 
Structure of Sulforhodamine B 
 
 
 
Fig. No: 17 
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5.29. ITEMS SUPPLIED 
Table No : 5 
Description Size 
SRB dye(sulphorhodamine B) 0.4 gm 
Fixative reagent 60 ml 
Dye ash solution 10x 100ml 
SRB solubilization Buffer 200ml 
 
5.30. STORAGE CONDITION  
The kit is shipped at ambient  temperature . Store all kit components at room 
temperature protected from light .The kit components are stable for one year when 
stored as recommended.
 (39) 
5.31. ADDITIONAL Items Required:  
• Microplate reader capable of readout between 550 and 580nm     
• 96 well tissue culture plates. 
5.32. PREPARATION BEFORE  USE:   
1. Dilute the Dye Wash Solution by adding 1 part 10X Dye Wash Solution to 9 par
ts distilled water. You require ~0.8ml per well to sufficiently wash the wells.  
2. In a clean amber glass or plastic container, add 100ml 1X Dye Wash Solution. 
Remove 1ml 1X Dye Wash Solution and add to the SRB Dye vial, pipette up 
and down to resuspend and transfer the entire contents to the 100ml 1X Dye Wa
sh Solution.  Stir to mix.  The SRB Dye Solution can be stored at room temperat
ure  
protected from light.  Crystals may form during storage, remove byfiltering with
 a syringe filter prior to use in the assay.  
5.33. SRB ASSAY 
PROCEDURE: 
The monolayer cell culture was trypsinizedand the cell count was adjusted to 
0.5-1.0 x 105 cells/ml using medium containing 10% new born sheep serum. To each 
well of the 96 well microtitre plate, 0.1ml of the diluted cell suspension 
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(approximately 10,000 cells) was added. After 24 hours, when a partial monolayer 
was formed, the supernatant was flicked off, washed once and 100 µl of different test 
compound concentrations were added to the cells in microtitre plates. The plates were 
then incubated at 37oC for 72 hours in 5% CO2 incubator, microscopic examination 
was carried out, and observations recorded  every 24 hours. After 72 hours, 25 µl of 
50% trichloroacetic acid was added to the wells gently such that it forms a thin layer 
over the test compounds to form overall concentration 10%. The plates were 
incubated at 4 
o
C for one hour. The plates were flicked and washed five times with tap 
water to remove traces of medium, sampleand serum, and were then air-dried. The 
air-dried plates were stained with 100μl SRB and kept for 30 minutes at room 
temperature. The unbound dye was removed by rapidly washing four times with 1% 
acetic acid. The plates were then air dried. 100 µl of 10mM Tris base was then added 
to the wells to solubilise the dye. . The plates were shaken vigorously for 5 minutes. 
The absorbance was measured usingmicroplate reader at a wavelength of 540nm22. 
The percentage growth inhibition was calculated using following formula,
(54)
 The 
percentage growth inhibition was calculated using following formula,  
%cell inhibition= 100-{(At-Ab)/ (Ac-Ab)} x100  
Where,  
At= Absorbance value of test compound  
Ab= Absorbance value of blank  
Ac=Absorbance value of control . 
The Cell growth was determined by subtracting average absorbance value of 
respective blank from the average absorbance value of respective blank from the 
average absorbance value of experimental set. Percent growth in presence of test 
material was calculated as under: 
 OD Change in presence of control = Mean OD of control- Mean OD of blank. 
 OD Change in presence of test sample = Mean OD of test sample- Mean OD 
of blank. 
 % Growth in presence of control = 100/OD change in presence of control. 
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 % Growth in presence of test sample= % Growth in presence of control × OD 
change in presence of test sample. 
 % Inhibition by test sample = 100 - % Growth in presence of test sample. 
The growth inhibition of 70% or above was considered active  
while testing extracts, but in testing of active ingredients at different molar 
concentrations, the growth inhibition of 50% or above as the criteria of 
activity. 
5.34. STATISTICAL ANALYSIS 
 All Experiments were repeated atleast three times.  Atleast quadruplicate 
cultures were scored for an experimental point.  All values were expressed as mean + 
S.E.M. The Student’s one tail T-Test was applied for statistical treatment of the result 
; PC 0.05 were considered as the statiscally significant value.  
5.35. METRIALS AND METHODS 
5.36. LIST OF MATERIALS USED : 
Table No : 1 
Consumables Manufacturer 
Absolute Methanol Marck Specialities Pvt Ltd, Mumbai 
Alpha naphthol Qualigens Fine Chemicals, Mumbai 
Ammonia Solution Qualigens Fine Chemicals, Mumbai 
Benedicts reagent Qualigens Fine Chemicals, Mumbai 
Benzene Himedia laboratories Pvt Limited, Mumbai 
Bromine Solution Sigma Aldrich Chemicals, Bangalore 
Chloroform Qualigens Fine Chemicals, Mumbai 
Copper sulphate Loba Chemie Pvt Ltd, Mumbai 
Distilled Water Aqua Purification Systems, Salem 
Dragendroff’s reagen Reachem laboratory chemicals, Chennai 
Fehlings A and B Qualigens Fine Chemicals, Mumbai 
Ferric chloride Loba Chemie Pvt Ltd, Mumbai 
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Ferrous sulphate Loba Chemie Pvt Ltd, Mumbai 
Glacial acetic acid Qualigens Fine Chemicals, Mumbai 
Hager’reagent Reachem Laboratory Chemicals, Chennai 
Hydrochloric acid Loba Chemic Pvt Ltd, Mumbai 
Iodine Qualigens Fine Chemicals, Mumbai 
Lead acetate Merck Specialities Pvt Ltd, Mumbai 
Mayer’s reagent Reachem Laboratory Chemicals, Chennai 
Millor’s reagent Reachem Laboratory Chemicals, Chennai 
Ninhydrin reagent Qualigens Fine Chemicals, Mumbai 
Nitric acid Qualigens Fine Chemicals, Mumbai 
Potassium acetate Qualigens Fine Chemicals, Mumbai 
Pyridine Merck Specialities Pvt Ltd, Mumbai 
Silver nitrate Qualigens Fine Chemicals, Mumbai 
Sodium amalgam Sigma Aldrich Chemicals, Bangalore 
Sodium carbonate Qualigens Fine Chemicals, Mumbai 
Sodium hydroxide Qualigens Fine Chemicals, Mumbai 
Sodium nitroprusside Loba Chemie Pvt Ltd, Mumbai 
Sodium Picrate Loba Chemie Pvt Ltd, Mumbai. 
 
 
 
CHAPTER 6                                                                                                   RESULT 
 
J.K.K.Nattraja College of Pharmacy,Komaraplayam Page 60 
 
                          6.RESULT 
6.1 PRELIMINARY PHYTOCHEMICAL SCREENING OF AQUEOUS AND 
METHANOLIC EXTRACT OF WHOLE PLANT OF ABUTILON INDICUM. 
 The preliminary phytochemical screening of abution indicum whole plant 
extreats showed presense of sterols, Carbohydrates, Proteins, Flavanoids, Glycosides, 
Mucilages, Tannins, Saponins of Volatile oil respectively in different extracts. (Table 
No. 4) 
Table No : 4 
Test Drug coarse 
powder 
Aqueous Methanol 
Sterols + _ _ 
Terepinoids _ _ _ 
Carbohydrates + + + 
Protiens + + + 
Flavanoids + + + 
Alkaloids + + + 
Glycosides + + + 
Mucilages + _ + 
Tannins + _ + 
Saponins + + + 
Volatile oil + + + 
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6.2 EXPERIMENTAL METHODS 
6.3. ANTI TUMOR ACTIVITY OF ABUTILON INDICUM IN DIFFERENT CELL LINES 
Table No: 
 
 
Extract 
Con-
centration 
Breast Colon Lung  
Liver 
HEP2 
Ovary- 
OVCAR5 
Pros-
tate 
DU 
145 
mcf-7 2R-75-
1 
colo-
205 
Sw 
620 
A-549 Ncl-H23 
Growth Inhibition 
Aqueous 100 0 0 64 0 63 0 0 0 0 
Methanol 100 20 45 88 88 72 0 72 80 0 
Positive controls Conc 
(molar) 
- - - - - - - - - 
5-fluro –uracil 2×10
-5
M - - - 60 - - - - - 
Paclitaxel 1×10
-6
M - - 70 - 71 60 - 66 62 
Adriamycin 1×10
-6
M 82 83 - - - - - - - 
Mitomycin 1×10
-6
M - - - - - - 74 - - 
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6.3. REPRESENTATION OF METHANOLIC AND ACQUEOUS EXTRACT 
AGAINST THE POSITIVE CONTROL 
 
Fig. No: 18 
6.4. REPRESENTATION OF METHANOLIC AND ACQUEOUS EXTRACT 
AGAINST THE POSITIVE CONTROL 
 
 Fig. No: 19 
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6.5. EFFECT OF STANDARD DRUG 
 
Fig. No: 20 
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7. DISCUSSION 
           Ever since the existence of human being, plants have been exploited for several 
purposes incluing medicinal poses. Plants are the primary source of biologically 
active phytochemicals present in conventinal medicaments. Medicinal systems 
viz.,Ayurveda,Unani an sidda employ the use of plants for treatment of diseases. 
Ethnobotanical studies highlight the relationships between various cultures and the 
traditional use of plants. Several ethnic groups all over the worl employ a number of 
plant species for treatment of various ailments ranging from mild infections to fatal 
infections. Often, these studies are of importance and provide essential information 
for development of scientific research to justify the therapeutic potential of plants 
(40) 
             The result of the study shows Methanolic and Aqueous Extract possessed 
Anti tumor properties comparing these to extract Methanolic extract is more potent 
than Aqueous extract. 
                                 )  were evaluated against six different cell lines (Lung 
A549,NCI-H23, Colon -205,SW- 620, Liver- HEP- 2, Ovary –OVCAR—5, Breast- 
mcf- 7, Prostate – DU – 145). Comparing Methanolic and Aqueous extracts the 
Methanolic extract exhibited 95% of the Anti tumor potential against the Human 
Cancer cell orgins. 
           The growth inhibition of 70% was considered active while testing extracts, but 
in testing of active ingredients at different molar concentrations, the growth inhibition 
of 50% or above was the criteria of activity. 
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8. CONCLUSION 
Natural products discovered from medicinal plants have played an important 
role in the treatment of Tumor .The present study points to the potential anti tumor 
activity of Aqueous and Methanol extract  of Abutilon Inicum. Further studies  to 
characterize the active principles and elucidate the mechanism of the action of 
Aqueous an Methanol extract are in Progress. 
Hence the plant extract may have clinical and therapeutic proposition in the 
most life threaten disease like tumor and further studies are required to investigate the 
plant sample as antineoplastic agent. Therefore, it is anticipated that plant can provide 
potential bioactive compounds for the development of new ‘leads’ to combact cancer 
diseases. 
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